Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.33 |
| ▸ | HSD11B2 | P80365 | 1/20 | 0.33 |
| ▸ | EPAS1 | Q99814 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11066714 | 1.00 | ALDH1A1 (0.54) | ALDH1A1HSD11B1HSD11B2EPAS1 | |
| SCHEMBL19253228 | 1.00 | ALDH1A1 (0.54) | ALDH1A1HSD11B1HSD11B2EPAS1 | |
| SCHEMBL19253305 | 1.00 | ALDH1A1 (0.54) | ALDH1A1HSD11B1HSD11B2EPAS1 | |
| SCHEMBL3774067 | 0.96 | ALDH1A1 (0.50) | ALDH1A1HSD11B1HSD11B2 | |
| Fluoride SCHEMBL28120802 | 0.96 | ALDH1A1 (0.50) | ALDH1A1HSD11B1HSD11B2 | |
| SCHEMBL11848572 | 0.96 | ALDH1A1 (0.50) | ALDH1A1HSD11B1HSD11B2 | |
| SCHEMBL9431032 | 0.96 | ALDH1A1 (0.50) | ALDH1A1HSD11B1HSD11B2 | |
| Cyclopentane SCHEMBL2308133 | 0.96 | ALDH1A1 (0.50) | ALDH1A1HSD11B1HSD11B2 | |
| SCHEMBL15014301 | 0.96 | ALDH1A1 (0.50) | ALDH1A1HSD11B1HSD11B2 | |
| SCHEMBL11816322 | 0.96 | ALDH1A1 (0.46) | ALDH1A1HSD11B1HSD11B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1617 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120043689-A | Device and method for testing performance of pressure sensor for powder vacuum stability test | 西安近代化学研究所 | 2025-05-27 | — | — | CN | claimed |
| CN-115869969-B | Dehydrogenation catalyst, preparation method thereof and dehydrogenation method | 中安浩源(上海)氢能科技有限公司 | 2024-09-06 | — | — | CN | claimed |
| CN-117816193-A | Catalyst for preparing perhydro phenanthrene by phenanthrene hydrogenation, preparation method and application thereof | 太原理工大学 | 2024-04-05 | — | — | CN | claimed |
| CN-112867728-B | Copper-chelated (pyridylmethylene) butanediamine derivatives | 冷泉港实验室 | 2024-04-05 | — | — | CN | claimed |
| US-11950504-B2 | Polycyclic compound and organic light emitting diode comprising same | LG CHEM, LTD. (KR) | 2024-04-02 | — | — | US | claimed |
| CN-112236434-B | Polycyclic compound and organic light emitting device including the same | 株式会社LG化学 | 2024-02-23 | — | — | CN | claimed |
| CN-117446750-A | Organic hydride compound system and application | 中国石油大学(华东) | 2024-01-26 | — | — | CN | claimed |
| CN-112705240-B | Catalyst carrier, dehydrogenation catalyst and liquid phase dehydrogenation method | 中国石油化工股份有限公司 | 2023-07-04 | — | — | CN | claimed |
| CN-112707784-B | Dehydrogenation method of organic liquid | 中国石油化工股份有限公司 | 2023-05-02 | — | — | CN | claimed |
| CN-111054325-B | Preparation and application of liquid phase dehydrogenation catalyst | 中国石油化工股份有限公司 | 2023-05-02 | — | — | CN | claimed |
| WO-1996009297-A1 | COMPOSITIONS AND METHODS FOR TREATING MAST-CELL INFLAMMATORY CONDITION | ARRIS PHARMACEUTICAL CORPORATION (US) | 1996-03-28 | — | — | WO | claimed |
| US-5407676-A | Hydrophilic form of perfluoro compounds and a method of manufacture | FUISZ TECHNOLOGIES LTD. (US) | 1995-04-18 | — | — | US | claimed |
| WO-1993018748-A1 | COMPOSITIONS COMPRISING A DRUG DELIVERY VEHICLE SUSPENDED IN A NONAQUEOUS FLUORINATED LIQUID | ALLERGAN, INC. (US) | 1993-09-30 | — | — | WO | claimed |
| US-5196199-A | Medium for topical application; melt spinning compound with a sugar | FUISZ TECHNOLOGIES LTD. (US) | 1993-03-23 | — | — | US | claimed |
| EP-0492707-A2 | Hydrophilic form of perfluoro compounds and method of manufacture | FUISZ TECHNOLOGIES LTD. (US) | 1992-07-01 | — | — | EP | claimed |
| US-5062902-A | Fluxing agents comprising β-diketone and β-ketoimine ligands and a process for using the same | AIR PRODUCTS AND CHEMICALS, INC. (US) | 1991-11-05 | — | — | US | claimed |
| US-5009725-A | Removal of surface oxides by forming metal-ligand complex; sublimination | AIR PRODUCTS AND CHEMICALS, INC. (US) | 1991-04-23 | — | — | US | claimed |
| US-4460557-A | Starting pitches for carbon fibers | NIPPON OIL CO., LTD. (JP) | 1984-07-17 | — | — | US | claimed |
| US-4434073-A | Perhydrophenanthrene derivatives, their preparation, and their use in liquid-crystalline dielectrics and electro-optical display elements | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1984-02-28 | — | — | US | claimed |
| US-3944626-A | Process for producing adamantane compounds | IDEMITSU KOSAN COMPANY LIMITED, (JP) | 1976-03-16 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11950504-B2 | Polycyclic compound and organic light emitting diode comprising same | CCNL2, DRD1, DRD4 | ALDH1A1 217/4885HSD11B1 463/4885HSD11B2 525/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.